Lineage Cell Therapeutics (LCTX) Earnings
|
Expand Research on LCTX
| Next EPS Date | 5/9/24 | EPS Growth Rate | -33.3% |
|---|---|---|---|
| Average EPS % Beat Rate | -47.5% | Revenue Growth Rate | -70.9% |
| Average % Move 1-Wk after EPS | -5.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/9/24 | Q124 | N/A | -$0.04 | N/A | N/A | $695.33K | N/A | N/A | N/A | ||
| 3/14/24 | Q423 | N/A | -$0.04 | N/A | N/A | $2.49M | N/A | N/A | N/A | ||
| 11/9/23 | Q323 | -$0.04 | -$0.05 | +$0.01 | $1.25M | $2.6M | N/A |  | | Details | |
| 8/10/23 | Q223 | -$0.03 | -$0.04 | +$0.01 | $3.23M | $2.2M | N/A | | | Details | |
| 5/11/23 | Q123 | -$0.03 | -$0.05 | +$0.02 | $2.39M | $1.22M | N/A | | | Details | |
| 3/9/23 | Q422 | -$0.15 | -$0.04 | -$0.11 | $14.7M | $2.57M | N/A | | | Details | |
| 11/10/22 | Q322 | -$0.04 | -$0.03 | -$0.01 | $3M | $3.82M | N/A | | | Details | |
| 8/11/22 | Q222 | -$0.04 | -$0.03 | -$0.01 | $4.15M | $3.68M | N/A | | | Details |
